For bladder and bowel symptoms
Take your first step toward freedom.
If you’re experiencing bladder or bowel symptoms,
there are steps you can take to take back control. Alert Important safety information
Steps to help bowel or bladder problems
Talking to your healthcare provider about your bothersome bladder or bowel symptoms can be uncomfortable, but you deserve long-lasting relief. Remember, if you have not experienced the symptom relief you want, more options are available.
Why am I having these symptoms?
Step 1:
Diagnosis
Reach out to a healthcare provider
Start by speaking with a healthcare provider. You may be asked to fill out a symptom tracker. This symptom tracker will help you and your healthcare provider have a meaningful conversation about your symptoms.
What treatments are prescribed first?
Step 2:
Lifestyle changes
Could conservative treatments help?
Conservative treatments may help, and while they don’t work for everyone, they may be the solution you need.
Bladder control
- Diet and exercise: Changes may include decreasing your caffeine intake and getting more exercise.
- Bladder retraining: This involves going to the bathroom on a schedule.
- Pelvic floor strengthening: This can be accomplished through Kegel exercises, which involve repeatedly contracting and relaxing the muscles of the pelvic floor.
Bowel control
- Dietary modification: Changes may include adjusting fiber intake or eliminating troublesome foods.
- Bowel retraining: This step aims to improve bowel sensation, coordination, and strength.
Could medications help?
Step 3: Medications
Trying medications
When lifestyle changes don’t deliver the results you want, oral medications may be the next step. These medications can help control symptoms but may have side effects.
In one survey regarding bladder control, 72% of people said they stopped taking their medication after just six months.1 If medications don’t work, or if you experience intolerable side effects, don’t lose hope. There is more you can try.
Is there an option for long-lasting relief?
Step 4:
Advanced therapies
The InterStim™ system works differently
If exercises, lifestyle changes, and medications disappoint, you may be ready for a more advanced option.
The InterStim™ system is a small, implantable device that targets the sacral nerves that control your bladder or bowel. It may help restore‡ normal bladder or bowel function2-5 — giving you the long-lasting relief you deserve.
Targeting the sacral nerves that control bladder and bowel function2-5, the InterStim™ system comes with a number of benefits:
- A trial period with an external device, so you can try it before you commit
- Greater effectiveness than medication¶ alone for OAB patients at 6 months6
- An 82% success rate at five years for OAB patients7# and an 89% improvement for patients experiencing bowel control symptoms8§**
In addition to risks related to surgery, complications can include pain at the implant sites, new pain, infection, lead (thin wire) movement/migration, device problems, undesirable changes in urinary or bowel function, and uncomfortable stimulation (sometimes described as a jolting or shocking feeling). Talk with your doctor about ways to minimize these risks.
Patients† have reported a 3 times greater improvement in quality of life with the InterStim™ system compared to using medications alone.6
Learn more
Additional advanced treatment options
For bladder control
Medtronic bladder control therapy delivered by the NURO™ system targets the tibial nerve to help you restore|| control of your bladder††. By restoring bladder function, this therapy, sometimes called percutaneous tibial neurostimulation (PTNM), puts you on a path to fewer trips to the bathroom, fewer pads per day, and more of the activities you enjoy.9-12
With the NURO™ system, you may experience:
- Restored bladder function8,9,||
- Convenience of a non-surgical, in-office treatment
- Resources and support
Most common side effects are temporary and include mild pain or skin inflammation at or near the stimulation site. The NURO™ system does not treat symptoms of urinary retention.
Injected medications
Injected medications may temporarily treat symptoms but raise other concerns, including:
- Repeated injections every three to six months
- A potential need for self-catheterization10
- Increased risk of bladder infection due to self-catheterization10
For bowel control
A bulking agent
This gel is injected into the anal canal to thicken the tissues and improve symptoms of fecal incontinence (FI), but has some potential concerns:
- May cause unpleasant side effects
Other surgical options
Several other surgical options are available, all of which bring their own unique set of benefits and risks, including:
- Anal sphincter repair
- Artificial sphincter
- Colostomy
Contact us
Have more questions?
Don’t hesitate to reach out.
Patient services specialist:
(800) 510-6735
Are you a candidate for InterStim™ therapy?
Answer a few short questions and find out if sacral neuromodulation may be a fit.
Medtronic provides results based on proximity to the search criteria. The results shown here are populated by your selections and may not include the full list of available providers.
Medtronic provides this listing to assist indicated patients’ access to care. Medtronic has no vested interest in any specific provider, nor do we provide any recommendation, assurance, or guarantee with respect to their service. Medtronic does not verify or monitor the license, credentials, accreditations or qualifications of any provider listed in the Physician Finder. Information on this site should not be used as a substitute for physician consultation. Patients should always talk with their provider about diagnosis and treatment information. The list of providers may not include all of those in your area who are qualified to deliver care. There is no cost associated for providers to be included on this list. Some providers on this list may purchase products from Medtronic or may act as paid consultants to Medtronic.
*
Third-party brands are trademarks of their respective owners.
†
Reflects overactive bladder patients.
‡
Restored function defined as ≥50% reduction in dysfunctional bladder or bowel symptoms from baseline.
§
Success defined as ≥ 50% reduction of episodes per week. This patient group had data at both baseline and the five-year visit. Another analysis reported 69% of people achieved success with Medtronic bowel control therapy. For this patient group, missing data at five years because of a device-related reason was counted as failure or if it was missing for non-device related reasons, the most recent data was carried forward.
||
Restored bladder function is defined as a measurable reduction in urinary frequency and/or urinary incontinence episodes following treatment.
¶
Anticholinergic/antimuscarinic
Numbers reflect as treated results, defined as subjects with diary data at baseline and 6 months (p=0.002). Intent to treat results, which include all randomized subjects, are 61% for SNM and 42% for SMT (p=0.02).
The most common device-related adverse events in SNM subjects were undesirable change in stimulation (10.2%, 6/59), implant site pain (8.5%, 5/59), lead migration/dislodgment (3.4%, 2/59), and implant site infection (3.4%, 2/59).
#
Numbers reflect completers analyses defined as patients with diary data at baseline and 5 years.
Success defined as a 50% or greater reduction in troublesome bladder symptoms.
The most common device-related AEs were undesirable change in stimulation (22%, 60/272), and implant site pain (15%, 40/272).
**
Numbers reflect completers analysis which included patients who had complete data at baseline and at annual visits. Clinical success was 69% and complete continence was 28% in the adjusted worst case analysis.
††
Restored bladder function is defined as a measurable reduction in urinary frequency and/or urinary incontinence episodes following treatment.
1
Yeaw J, Benner J, Walt JG et al. Comparing adherence and persistence across 6 chronic medication classes. J Manag Care Pharm. 2009:15(9):724–736.
2
Leng WW, Chancellor MB. How sacral nerve stimulation neuromodulation works. Urol Clin North Am. 2005;32(1):11–18.
3
Chancellor MB, Chartier Kastler EJ. Principles of sacral nerve stimulation (SNS) for the treatment of bladder and urethral sphincter dysfunctions. Neuromod. 2000;3(1):15-26.
4
Lundby L, Moeller A, Buntzen S, et al. Relief of fecal incontinence by sacral nerve stimulation linked to focal brain activation. Dis Colon Rectum. 2011;54(3):318-323.
5
Janssen PTJ, Komen N, Melenhorst J, et al. Sacral neuromodulation for fecal incontinence: a review of the central mechanisms of action. J Clin Gastroenterol. 2017;51(8):669-676.
6
Siegel S, Noblett K, Mangel J, et al. Results of a prospective, randomized, multicenter study evaluating sacral neuromodulation with InterStim™ therapy compared to standard medical therapy at 6-months in subjects with mild symptoms of overactive bladder. Neurourol Urodyn. 2015 Mar;34(3):224–230.
7
Siegel S, Noblett K, Mangel J, et al. Five-year follow-up results of a prospective, multicenter study of patients with overactive bladder treated with sacral neuromodulation. J Urol. 2018;199(1), 229–236.
8
Hull T, Giese C, Wexner SD, et al. Long-term durability of sacral nerve stimulation therapy for chronic fecal incontinence. Dis Colon Rectum. 2013; 56(2):234–245.
9
Kobashi K, Nitti V, Margolis E, et al. A prospective study to evaluate efficacy using the NURO percutaneous tibial neuromodulation system in drug-naïve patients with overactive bladder syndrome. J Urol. 2019;131:77–82.
10
Peters KM, Carrico DJ, et al. Randomized trial of percutaneous tibial nerve stimulation versus sham efficacy in the treatment of overactive bladder syndrome: results from the SUmiT trial. J Urol. 2010;183:1438-1443.
11
Kobashi K, Margolis E, Sand P, et al. Prospective study to evaluate quality of life with percutaneous tibial neuromodulation in drug-naïve patients with overactive bladder syndrome. Presented at the 2018 Annual Meeting of the International Continence Society.
12
Peters KM, MacDiarmid SA, Wooldridge LS, et al. Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the overactive bladder innovative therapy trial. J Urol. 2009;182(3):1055-1061.
Information on this site should not be used as a substitute for talking with your doctor. Always talk with your doctor about diagnosis and treatment information.